Press Releases for MRX

Press Releases
RidgewaterEquity.Com Free Fundamental Sector &Amp; Market Research on MRX, RPM, BKE, NMR, BLL and SSL
Morning Watch for Wednesday: Sunwin International Neutraceuticals - August 19, 2009
Medicis Reports Second Quarter 2009 Financial Results
Medicis Announces Second Quarter 2009 Conference Call and Webcast
Medicis and Revance Announce Agreement for Development of Next-Gen Neurotoxin
Medicis Announces Approval of New Strengths of SOLODYN(R)
Health Canada Issues LIPOSONIX(TM) System Medical Device License
Medicis Begins Shipping Dysport(TM) for Glabellar Lines
Medicis to Present At Jefferies Healthcare Conference
Medicis Declares Cash Dividend
Medicis Announces New Patents for SOLODYN(R) 90mg
PhotoMedex Reports First Quarter Results
Medicis to Present At Deutsche Bank Health Care Conference
Medicis Reports First Quarter 2009 Financial Results
Medicis Announces First Quarter 2009 Conference Call and Webcast
Ipsen and Medicis: FDA Approves DysportTM for Therapeutic and Aesthetic Uses
FDA Approves DYSPORT(TM) for Therapeutic and Aesthetic Uses
Medicis Announces New Notice of Allowance for SOLODYN(R) 90mg
Update on Ipsen's Botulinum Toxin Type A Product Regulatory Review Status in the US
Medicis Announces Availability of Online Proxy Materials for 2009
Medicis Announces Notice of Allowance for SOLODYN(R) 90mg
Medicis and Teva Announce Settlement Agreement
Teva Announces Approval and Launch of Generic Solodyn(R) Extended- Release Tablets
Medicis to Present At Cowen & Company Conference
Medicis Declares Cash Dividend - Mar 11 2009 8:15AM
IMPAX Reports Fourth Quarter and Full Year 2008 Financial Results - Feb 27 2009 11:00AM
Medicis Reports Fourth Quarter and Year-End 2008 Financial Results
Medicis Announces 2008 Fourth Quarter and Year-End Conference Call and Webcast
Medicis to Present At Roth Conference
Medicis to Present At Deutsche Bank Conference - Feb 10 2009 8:18AM
Medicis to Present At JP Morgan Healthcare Conference
Botox Still Hot Despite Cool Economy
Medicis Declares Cash Dividend - Dec 17 2008 8:08AM
Medicis to Present At RBC Capital Markets Healthcare Conference
Medicis and IMPAX Announce R&D Collaboration and Settlement
Investors of Medicis Pharmaceutical Corporation are Reminded by the Pomerantz Law Firm of Tuesday Lead Plaintiff Deadline -- MRX
Pomerantz Haudek Block Grossman & Gross LLP Reminds Investors of Medicis Pharmaceutical Corporation of December 2 Lead Plaintiff Deadline -- MRX
Medicis to Present At Credit Suisse Healthcare Conference
Medicis Reports Third Quarter 2008 Financial Results
Medicis Announces Third Quarter 2008 Conference Call and Webcast
Medicis Pharmaceutical Corporation Sued for Securities Violations by Pomerantz Haudek Block Grossman & Gross LLP -- MRX
The Pomerantz Firm Charges Medicis Pharmaceutical Corporation With Securities Fraud -- MRX
Bronstein, Gewirtz & Grossman, LLC Announces That a Class Action Has Been Filed Against Medicis Pharmaceutical Corporation
Izard Nobel LLP Announces Class Action Lawsuit against Medicis Pharmaceuticals Corporation
Coughlin Stoia Geller Rudman & Robbins LLP Files Class Action Suit Against Medicis Pharmaceutical Corporation
The Brualdi Law Firm, P.C. Announces Class Action Lawsuit Against Medicis Pharmaceutical Corporation
Medicis Announces FDA Approval of PMA Supplement for RESTYLANE
Federman & Sherwood Announces That a Securities Class Action Lawsuit Has Been Filed Against Medicis Pharmaceutical Corp. (NYSE: MRX)
Law Offices of Brodsky & Smith, LLC Announces Class Action Lawsuit Against Medicis Pharmaceutical Corp.
Leerink Swann Partners with American Society of Plastic Surgeons to Co-Host Investor Roundtable at 2008 Annual Meeting
Brower Piven Encourages Investors Who Have Losses in Excess of $250,000 From Investment in Medicis Pharmaceutical Corp. to Inquire About the Lead Plaintiff Position in Securities Fraud Class Action Lawsuit Before the December 2, 2008 Lead Plaintiff Deadline
Investor Alert: KGS Notifies Medicis Pharmaceutical Purchasers With Losses Greater Than $300,000, of Lead Plaintiff Application Deadline in Securities Class Action Lawsuit - MRX
The Rosen Law Firm Files Securities Class Action Charging Medicis Pharmaceutical Corp. With Violations of the Federal Securities Laws -- MRX
Medicis Announces Intent to Restate Financial Statements
Medicis Declares Cash Dividend - Sep 17 2008 8:20AM
Medicis to Present At Thomas Weisel Partners Healthcare Conference 2008
Medicis Reports Second Quarter 2008 Financial Results
Medicis Announces Second Quarter 2008 Conference Call and Webcast
Medicis Announces Close of LipoSonix Acquisition
Medicis to Acquire LipoSonix
Medicis Declares Cash Dividend - Jun 11 2008 8:05AM
Medicis to Present At Goldman Sachs Global Healthcare Conference
Medicis to Present At Citi Investment Research Healthcare Conference - May 27 2008 12:56AM
Ipsen and Medicis Announce Acceptance of Reloxin BLA in Aesthetics by FDA
Ipsen and Medicis Announce Acceptance of Reloxin(R) BLA in Aesthetics by FDA - Jun 2 2008 1:23AM
Perlane Celebrates Its One-Year Anniversary in U.S.
Medicis Reports First Quarter 2008 Financial Results
Medicis Announces First Quarter 2008 Conference Call and Webcast
Medicis to Present At Deutsche Bank Conference - Jun 2 2008 1:23AM
Medicis Announces the Early Adoption of Online Proxy Materials for 2008
Medicis Announces Organizational Changes